Roche would deliver 3 million antibody tests for the novel coronavirus to the German healthcare system in May, German Minister of Health Jens Spahn announced on Monday.
In the coming months, pharmaceutical company Roche, headquartered in Switzerland, would increase the delivery to 5 million antibody tests to Germany each month, according to Spahn.
Through the agreement, Germany would have a sufficient number of tests and could get a “picture of the outbreak to date and in the future,” said Spahn after visiting Roche’s production facility for the new test in the German state Bavaria.
“The new test is an important new milestone in the fight against the virus,” stressed Spahn.
On Sunday, Roche announced that the United States Food and Drug Administration (FDA) had issued an emergency use authorization for its new antibody test.
The antibody test was designed to help determine if a patient had been exposed to the coronavirus and if the patient had developed antibodies, according to Roche.
Global delivery of the new antibody test to laboratories had already begun, according to Roche. Additionally, total production capacity would be ramped up to high double-digit millions per month in order to supply healthcare systems worldwide. Enditem